The report on the global genome engineering market discussed individual strategies, followed by company profile of manufacturer of genome engineering. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global genome engineering market.
Global Genome engineering Market - Segmentation
Technology |
Clustered regularly interspaced short palindromic repeats (CRISPR) Transcription activator-like effector nuclease (Talen) Zinc Finger Nuclease (ZFN) Other Technologies |
Application |
Cell Line Engineering Animal Genome Engineering Plant Genome Engineering Other Application |
End-user |
Pharmaceutical and Biotechnology Companies Academics Clinical Research Organizations |
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
The global genome engineering market was worth US$ 3,685.4 Mn and is projected to reach a value of US$ 9,595.2 Mn by the end of 2027
Genome engineering market is anticipated to grow at a CAGR of 10.9% during the forecast period
North America accounted for a major share of the global genome engineering market
Genome engineering market is driven by increased funding in genomic research, technological developments, rising demand for synthetic genes, and investment by pharmaceutical companies for new product development
Key players in the global genome engineering market include Applied Stem Cell, Inc., GenScript, Horizon Discovery Group plc, Integrated DNA Technologies, Inc., Lonza Group Ltd., New England Biolabs, OriGene Technologies, Inc., Sangamo BioSciences, Inc., Sigma-Aldrich Co. LLC., Thermo Fisher Scientific, Inc., and Transposagen Biopharmaceuticals, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Genome Engineering Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Genome Engineering Market Analysis and Forecasts, 2018–2030
5. Key Insights
5.1. Technological Advancements
5.2. Healthcare Industry Overview
6. Global Genome Engineering Market Analysis and Forecasts, By Technology
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Technology, 2018–2030
6.3.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
6.3.2. Transcription activator-like effector nuclease (Talen)
6.3.3. Zinc Finger Nuclease (ZFN)
6.3.4. Others
6.4. Market Attractiveness By Technology
7. Global Genome Engineering Market Analysis and Forecasts, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2018–2030
7.3.1. Cell Line Engineering
7.3.2. Animal Genome Engineering
7.3.3. Plant Genome Engineering
7.3.4. Others
7.4. Market Attractiveness By Application
8. Global Genome Engineering Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2018–2030
8.3.1. Pharmaceutical and Biotechnology Companies
8.3.2. Academics
8.3.3. Clinical Research Organizations
8.4. Market Attractiveness By End-user
9. Global Genome Engineering Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Region
10. North America Genome Engineering Market Analysis and Forecast
10.1. Introduction
10.2. Market Value Forecast By Technology, 2018–2030
10.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
10.2.2. Transcription activator-like effector nuclease (Talen)
10.2.3. Zinc Finger Nuclease (ZFN)
10.2.4. Others
10.3. Market Value Forecast By Application, 2018–2030
10.3.1. Cell Line Engineering
10.3.2. Animal Genome Engineering
10.3.3. Plant Genome Engineering
10.3.4. Others
10.4. Market Value Forecast By End-user, 2018–2030
10.4.1. Pharmaceutical and Biotechnology Companies
10.4.2. Academics
10.4.3. Clinical Research Organizations
10.5. Market Value Forecast By Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Technology
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Genome Engineering Market Analysis and Forecast
11.1. Introduction
11.2. Market Value Forecast By Technology, 2018–2030
11.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
11.2.2. Transcription activator-like effector nuclease (Talen)
11.2.3. Zinc Finger Nuclease (ZFN)
11.2.4. Others
11.3. Market Value Forecast By Application, 2018–2030
11.3.1. Cell Line Engineering
11.3.2. Animal Genome Engineering
11.3.3. Plant Genome Engineering
11.3.4. Others
11.4. Market Value Forecast By End-user, 2018–2030
11.4.1. Pharmaceutical and Biotechnology Companies
11.4.2. Academics
11.4.3. Clinical Research Organizations
11.5. Market Value Forecast By Country, 2018–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Technology
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country
12. Asia Pacific Genome Engineering Market Analysis and Forecast
12.1. Introduction
12.2. Market Value Forecast By Technology, 2018–2030
12.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
12.2.2. Transcription activator-like effector nuclease (Talen)
12.2.3. Zinc Finger Nuclease (ZFN)
12.2.4. Others
12.3. Market Value Forecast By Application, 2018–2030
12.3.1. Cell Line Engineering
12.3.2. Animal Genome Engineering
12.3.3. Plant Genome Engineering
12.3.4. Others
12.4. Market Value Forecast By End-user, 2018–2030
12.4.1. Pharmaceutical and Biotechnology Companies
12.4.2. Academics
12.4.3. Clinical Research Organizations
12.5. Market Value Forecast By Country, 2018–2030
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Technology
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country
13. Latin America Genome Engineering Market Analysis and Forecast
13.1. Introduction
13.2. Market Value Forecast By Technology, 2018–2030
13.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
13.2.2. Transcription activator-like effector nuclease (Talen)
13.2.3. Zinc Finger Nuclease (ZFN)
13.2.4. Others
13.3. Market Value Forecast By Application, 2018–2030
13.3.1. Cell Line Engineering
13.3.2. Animal Genome Engineering
13.3.3. Plant Genome Engineering
13.3.4. Others
13.4. Market Value Forecast By End-user, 2018–2030
13.4.1. Pharmaceutical and Biotechnology Companies
13.4.2. Academics
13.4.3. Clinical Research Organizations
13.5. Market Value Forecast By Country, 2018–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Technology
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country
14. Middle East & Africa Genome Engineering Market Analysis and Forecast
14.1. Introduction
14.2. Market Value Forecast By Technology, 2018–2030
14.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
14.2.2. Transcription activator-like effector nuclease (Talen)
14.2.3. Zinc Finger Nuclease (ZFN)
14.2.4. Others
14.3. Market Value Forecast By Application, 2018–2030
14.3.1. Cell Line Engineering
14.3.2. Animal Genome Engineering
14.3.3. Plant Genome Engineering
14.3.4. Others
14.4. Market Value Forecast By End-user, 2018–2030
14.4.1. Pharmaceutical and Biotechnology Companies
14.4.2. Academics
14.4.3. Clinical Research Organizations
14.5. Market Value Forecast By Country, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Technology
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2019)
15.3. Company Profiles
15.3.1. Applied Stem Cell, Inc.
15.3.2. GenScript
15.3.3. Horizon Discovery Group plc
15.3.4. Integrated DNA Technologies, Inc.
15.3.5. Lonza Group Ltd.
15.3.6. New England Biolabs
15.3.7. OriGene Technologies, Inc.
15.3.8. Sangamo BioSciences, Inc.
15.3.9. Sigma-Aldrich Co. LLC.
15.3.10. Thermo Fisher Scientific, Inc.
15.3.11. Transposagen Biopharmaceuticals, Inc.
List of Table
Table 01 Genome engineering Market Size (US$ Mn) Forecast, By Technology, 2019–2027
Table 02 Genome engineering Market Size (US$ Mn) Forecast, By Application, 2019–2027
Table 03 Genome engineering Market Size (US$ Mn) Forecast, By End-user, 2019–2027
Table 04 Genome engineering Market Size (US$ Mn) Forecast, By Geography, 2019–2027
Table 05 North America Genome engineering Market Size (US$ Mn) and Forecast, By Technology ,2019–2027
Table 06 North America Genome engineering Market Size (US$ Mn) and Forecast, By Application ,2019–2027
Table 07 North America Genome engineering Market Size (US$ Mn) and Forecast, By End-user,2019–2027
Table 08 Europe Genome engineering Market Size (US$ Mn) and Forecast, By Technology ,2019–2027
Table 09 Europe Genome engineering Market Size (US$ Mn) and Forecast, By Application, 2019–2027
Table 10 Europe Genome engineering Market Size (US$ Mn) and Forecast, By End-user,2019–2027
Table 11 Asia Pacific Genome engineering Market Size (US$ Mn) and Forecast, By Technology ,2019–2027
Table 12 Asia Pacific Genome engineering Market Size (US$ Mn) and Forecast, By Application ,2019–2027
Table 13 Asia Pacific Genome engineering Market Size (US$ Mn) and Forecast, By End-user,2019–2027
Table 14 Latin America Genome engineering Market Size (US$ Mn) and Forecast, By Technology ,2019–2027
Table 15 Latin America Genome engineering Market Size (US$ Mn) and Forecast, By Application ,2019–2027
Table 16 Latin America Genome engineering Market Size (US$ Mn) and Forecast, By End-user,2019–2027
Table 17 Middle East & Africa Genome engineering Market Size (US$ Mn) and Forecast, By Technology ,2019–2027
Table 18 Middle East & Africa Genome engineering Market Size (US$ Mn) and Forecast, By Application ,2019–2027
Table 19 Middle East & Africa Genome engineering Market Size (US$ Mn) and Forecast, By End-user,2019–2027
List of Figure
Figure 01 Genome engineering Market Snapshot
Figure 02 Genome engineering Market Size (US$ Mn) and Forecast, 2019–2027
Figure 03 Genome engineering Technology Market Revenue (US$ Mn) and Y-o-Y growth (%), 2019–2027
Figure 04 Genome engineering Market Attractiveness Analysis By Technology
Figure 05 Genome engineering Market Attractiveness Analysis By Application
Figure 06 Genome engineering Market Attractiveness Analysis By End-user
Figure 07 North America Genome engineering Value Share Analysis, By Technology, 2019 and 2027
Figure 08 North America Genome engineering Value Share Analysis, By Application, 2019 and 2027
Figure 09 North America Genome engineering Value Share Analysis, By End-user, 2019 and 2027
Figure 10 Europe Genome engineering Value Share Analysis, By Technology, 2019 and 2027
Figure 11 Europe Genome engineering Value Share Analysis, By Application, 2019 and 2027
Figure 12 Europe Genome engineering Value Share Analysis, By End-user, 2019 and 2027
Figure 13 Asia Pacific Genome engineering Value Share Analysis, By Technology, 2019 and 2027
Figure 14 Asia Pacific Genome engineering Value Share Analysis, By Application, 2019 and 2027
Figure 15 Asia Pacific Genome engineering Value Share Analysis, By End-user, 2019 and 2027
Figure 16 Latin America Genome engineering Value Share Analysis, By Technology, 2019 and 2027
Figure 17 Latin America Genome engineering Value Share Analysis, By Application, 2019 and 2027
Figure 18 Latin America Genome engineering Value Share Analysis, By End-user, 2019 and 2027
Figure 19 Middle East & Africa Genome engineering Value Share Analysis, By Technology, 2019 and 2027
Figure 20 Middle East & Africa Genome engineering Value Share Analysis, By Application, 2019 and 2027
Figure 21 Middle East & Africa Genome engineering Value Share Analysis, By End-user, 2019 and 2027